China
Everest Medicines' Partner Calliditas Reports Positive Phase 3 Results for Nefecon in IgA Nephropathy Trial
The trial met its primary endpoint with Nefecon demonstrating a highly statistically significant benefit over placebo (p value < 0.0001) in estimated gl...
March 14, 2023 | News
Boan Biotech Completes Patient Enrollment for Aflibercept Trial in China
Aflibercept is a homodimeric fusion protein consisting of portions of human vascular endothelial growth factor receptor (VEGFR) extracellular domains (VEGF...
March 13, 2023 | News
Zhongchao Inc. Survey: 80% of Bone Marrow Cancer Patients Satisfied with Services
The survey revealed that approximately 80.6% of patients gave full marks to the patient services provided by Zhongxin Health platform. Zhongxin Health pro...
March 13, 2023 | News
JW Therapeutics Starts Clinical Trial of Carteyva® for High-Risk Large B-Cell Lymphoma
High-risk large B-cell lymphoma includes large B-cell lymphoma with International Prognostic Index (IPI) score ≥3, and high-grade B-cell lymphoma (HGBL)...
March 09, 2023 | News
GenScript ProBio Congratulates Eutilex's IND Clearance from MFDS
GenScript ProBio extends congratulations on this. 2 years ago, GenScript ProBio and Eutilex announced that the parties entered into strategic collaboration...
March 07, 2023 | News
Harbour BioMed's Batoclimab Shows Positive Results in Phase III Trial for Myasthenia Gravis
Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel ant...
March 06, 2023 | News
Porton Advanced and DanausGT Collaborate on Gene and Cell Therapy Development.
As an end-to-end gene and cell therapy service provider, Porton Advanced CDMO offers comprehensive solutions covering plasmids, cell therapy, gene therapy,...
March 02, 2023 | News
Sanyou Biopharmaceuticals expanding its business outreach to a central hub of biotech network
Sanyou Biopharmaceuticals, a leading provider of biotech CRDMO services, is opening a new office in Cambridge Innovation Centre, CIC, marking a new era tow...
March 02, 2023 | News
Robert Walters China Salary Survey 2023: Easing of Epidemic Control: Recruitment Market Stabilises, Data Security and Compliance Talent being Key Recruitment Targets
The demand for mid-to-senior professionals with specific technical skills and background is increasing, such as new energy, integrated circuits, medical de...
March 02, 2023 | Analysis
JW Therapeutics Announces Initiation of Clinical Study of JWATM214 in Patients with Advanced Hepatocellular Carcinoma
Primary hepatic cancer is a common malignant tumor of the digestive system worldwide, with high malignancy and hepatic prognosis. As the most common pathol...
March 01, 2023 | News
Everest Medicines Commences Operations at State-of-the-Art mRNA Vaccine Facility.
Everest Medicines (HKEX 1952.HK, "Everest" or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercializa...
February 28, 2023 | News
Porton Advanced and Yinjia Biosciences Partner to Enhance CDMO Technology Platform
Porton Advanced CDMO offers end-to-end gene and cell therapy services covering plasmids, cell therapy, gene therapy, oncolytic virus, mRNA therapy, and bac...
February 27, 2023 | News
Medtec China 2023 will be held on June 1-3, 2023, in Suzhou China
Meanwhile, the most recent COVID-19 prevention and control optimization policies have made it easier for overseas enterprises to participate in trade fairs...
February 27, 2023 | News
Keymed and Lepu Biopharma gain global exclusive license for CMG901 from AstraZeneca.
CMG901 is currently in a Phase I clinical trial for the treatment of Claudin 18.2-positive solid tumors. Preliminary results from the Phase 1 trial indicat...
February 24, 2023 | News
Most Read
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
